F ungal endocarditis is a rare but lethal disease with a mortality rate exceeding 50%.
Clinical Summary
A 45-year-old man underwent a complicated repair of an acute type A aortic dissection, including a mechanical valved root and ascending aortic and innominate arterial replacement, at another institution. Eight months later, the patient presented with a temperature of 103°F and right ankle cellulitis surrounding a spider bite. Blood cultures grew Candida dubliniensis. Transesophageal echocardiography (TEE) demonstrated a small vegetation above the left coronary os. The patient was started on a regimen of caspofungin and transferred to our institution.
Repeat TEE confirmed the presence of the vegetation. The results of repeat blood cultures were negative. The patient was now afebrile and had no clinical signs or symptoms of endocarditis. He was discharged home receiving intravenous caspofungin therapy.
At his follow-up examination 4 weeks later, the patient remained afebrile and asymptomatic, and the results of blood cultures were still negative. Repeat TEE and computed tomographic angiography (CTA) demonstrated an interval increase in the number and size of the vegetations (Figures 1 and 2, A) . He was started on a regimen of amphotericin B and underwent surgical exploration.
Opening of the ascending aortic graft revealed extensive and exophytic vegetations within the aortic root and ascending aortic and innominate arterial prosthetic grafts, with far more fungal burden seen than was predicted by either the TEE or CTA. All gross infection was confined to within the prosthetic grafts, with no invasion of the periannular structures. Immediate Gram staining revealed abundant budding yeast identified as Candida parapsilosis. All prosthetic graft, pledget material, and previously placed BioGlue (CryoLife, Inc, Kennesaw, Ga) were removed, and the arch was reconstructed during hypothermic circulatory arrest. The aortic graft, arch, and innominate arterial grafts were replaced with 28-mm and 12-mm polyester grafts. A 23-mm Medtronic Freestyle porcine bioprosthesis (Medtronic, Inc, Minneapolis, Minn) was used to replace the aortic root after complete debridement.
The patient had an uneventful hospital course receiving intravenous amphotericin B and oral 5-flucytosine and was discharged on day 12 with a prescription for these drugs. After 4 months, the antifungal regimen was changed to daily oral fluconazole for long-term suppression. After more than 12 months of follow-up, there have been no signs or symptoms of endocarditis. Follow-up TEE and CTA at 3, 6, and 12 months demonstrated no evidence of recurrent endocarditis (Figure 2, B) .
Discussion
Fungi are responsible for 1.3% to 6% of all cases of infective endocarditis.
1,2 Most cases are caused by Candida albicans, but Candida parapsilosis is a more commonly isolated non-albicans species. Fungal pathogens create a biofilm, which aids in adherence to endothelial or prosthetic surfaces and prevents antifungal penetration, enabling persistent and recurrent infection. 3 The high mortality rate of patients with fungal endocarditis correlates with a recurrence rate of 30%. 1, 2 An attempt at medical therapy is justified in patients with asymptomatic disease, particularly in the setting of reoperative cardiac surgery. 4 However, medically treated patients require close follow-up, regardless of symptomatology. In this case surveillance TEE demonstrated an interval increase in the size and number of vegetations after 4 weeks of intravenous antifungal therapy, but neither TEE nor CTA depicted the true fungal burden, which extended throughout the prosthetic graft material.
A porcine bioprosthetic root was a good option for this case because the fungal burden was not invading the heart or the native vessels, the annulus was small given the patient's size, and the bioprosthetic root offered a better valvular hemodynamic profile than a mechanical valve of equal size. Although, historically, homograft replacement has been touted as the optimal strategy for reoperative endocarditis, neither late survival nor reoperation-free survival has been shown to be reduced by homograft use compared with use of other biologic or mechanical valves. 5 Recurrences have been attributed to the discontinuation of long-term antifungal suppressive therapy and not to valve choice. 6 Freestyle bioroots now appear to offer better 8-year freedom from structural deterioration and aortic insufficiency than homografts, 7, 8 and they might be a better long-term option when invasive infection is not present.
We conclude from this case that failed medical therapy, as demonstrated by TEE indicating a progression of the size, number, or both of endocardial vegetations, can be a marker for more extensive endocardial fungal burden than is clinically apparent. This finding should prompt an aggressive multimodal strategy, including perioperative intravenous antifungal therapy, radical excision of infected prostheses and tissues, valve replacement, and long-term suppressive antifungal therapy. The patient described in this report continues to receive fluconazole and undergoes hepatic transaminase surveillance bimonthly and both TEE and CTA surveillance every 6 months. 
